null

Click on the links below to see details of all the cancer service guidance, published or in development, in this topic area.

Completed cancer service guidance

• Colorectal

Click on the links below to see details of all the clinical guidelines, published or in development, in this topic area.

Completed guidelines

• None

Guidelines in development

• Colorectal cancer

• Colorectal cancer in patients with ulcerative colitis, Crohn's disease and polyps

Click on the links below to see details of all the interventional procedures, published or in development, in this topic area.

Completed interventional procedures

• Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique)

• Computed tomographic colonography (virtual colonoscopy)

• Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis

• Laparoscopic gastrectomy for cancer

• Preoperative high dose rate brachytherapy for rectal cancer

• Radiofrequency ablation for the treatment of colorectal liver metastases

• Selective internal radiation therapy for colorectal metastases in the liver

• Thoracoscopically assisted oesophagectomy

Interventional procedures in development

• None

Click on the links below to see details of all the technology appraisals, published or in development, in this topic area.

Completed appraisals

• Colon cancer (adjuvant) - capecitabine and oxaliplatin

• Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (review)

• Colorectal cancer (first line) - cetuximab

• Colorectal cancer (metastatic) - bevacizumab & cetuximab

• Colorectal cancer (metastatic) - cetuximab (terminated appraisal)

• Colorectal cancer - capecitabine and tegafur uracil

• Colorectal cancer - laparoscopic surgery (replaced by TA105)

• Colorectal cancer - laparoscopic surgery (review)

• Gastro-intestinal stromal tumours (GIST) - imatinib

• Gastrointestinal stromal tumours - sunitinib

• Pancreatic cancer - gemcitabine

Appraisals in development

• Colon cancer (adjuvant) - irinotecan

• Colorectal cancer (metastatic) - bevacizumab

• Gastric cancer (advanced HER-2 positive) - trastuzumab (herceptin)

• Gastric cancer (advanced) - capecitabine

• Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review)

• Gastrointestinal stromal tumours - imatinib